Abbott is officially bringing the noise—literally—by launching a clinical trial for its new intravascular lithotripsy (IVL) ...

The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...

Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...

The DECADE data show a higher risk of death, MI, and stent thrombosis in people who smoked at the time of PCI with DES.

J&J acquired the IVL device maker Shockwave Medical last year for $13.1 billion, and Boston Scientific agreed to buy Bolt Medical in January for up to $664 million.

In 1994, the first coronary stent was created by J&J and was called the Palmaz-Schatz stent. This move revolutionised cardiology – coronary stents keep vessels open so blood can flow to the heart.

We value keeping the Device Guide up to date.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We value keeping the Device Guide up to date.